Showing results (101-110 of 302) with videos related to
Sort By:
Pageof 31
Diagnostic Pathology|May 23, 2013
Lack of SF3B1 R625 mutations in cutaneous melanomaBastian Schilling, Nicola Bielefeld, Antje Sucker, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2017
Impact of 18F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysisAndrea Forschner, Susann-Cathrin Olthof, Brigitte Gückel, et al.Microorganisms|March 6, 2021
Impact of the Histidine-Containing Phosphocarrier Protein HPr on Carbon Metabolism and Virulence in Staphylococcus aureusLinda Pätzold, Anne-Christine Brausch, Evelyn-Laura Bielefeld, et al.European Radiology|May 15, 2013
Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?Carolin Gramsch, Sophia L Göricke, Felix Behrens, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 5, 2016
Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanomaKatharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.The Oncologist|May 9, 2026
Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter studyElias A T Koch, Louisa A Schielein, Markus Reitmajer, et al.Plos One|May 26, 2018
Willingness to pay for a cure of low-risk melanoma patients in GermanyMatthias Augustin, Christine Blome, Andrea Forschner, et al.European Journal of Cancer (Oxford, England : 1990)|February 4, 2023
Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)Teresa Amaral, Tobias Sinnberg, Eftychia Chatziioannou, et al.Cancers|August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma PatientsFranz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 4, 2020
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an updateKatharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.Pageof 31